209
Pliant Therapeutics Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
340
FY23:
506
FY24:
362
FY25:
196
(positive)
Change from FY21 to FY25
millions USD
FY21:
11.8
FY22:
10.3
FY23:
6.65
FY24:
34.7
FY25:
28.8
Total assets
Change from FY21 to FY25
millions USD
FY21:
221
FY22:
351
FY23:
512
FY24:
397
FY25:
225
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
16.8
FY22:
23.9
FY23:
28.5
FY24:
33.2
FY25:
16.4
(negative)
Change from FY21 to FY25
millions USD
FY21:
5.33
FY22:
13.4
FY23:
10.1
FY24:
59.7
FY25:
27.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
199
FY22:
313
FY23:
474
FY24:
304
FY25:
181
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
221
FY22:
351
FY23:
512
FY24:
397
FY25:
225
All amounts in millions USD